4.50
-0.20
(-4.26%)
May 17 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 4.50 - 4.72 |
| 52 week | 3.21 - 8.00 |
| Open | 4.68 |
| Vol / Avg. | 9,799.00/12,000.00 |
| Mkt cap | 58.20M |
| P/E | - |
| Div/yield | - |
| EPS | -6.63 |
| Shares | 12.93M |
| Beta | 0.51 |
| Inst. own | 39% |
Events
Jul 29, 2013
Q2 2013 NCI, Inc. Earnings Release
Jun 5, 2013
NCI, Inc. Annual Shareholder Meeting
May 1, 2013
Q1 2013 NCI, Inc. Earnings Conference Call -
May 1, 2013
Q1 2013 NCI, Inc. Earnings Release - Tentative
Feb 28, 2013
Q4 2012 NCI, Inc. Earnings Conference Call -
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 2.16% | -23.57% |
| Operating margin | 3.92% | -38.01% |
| EBITD margin | - | 4.79% |
| Return on average assets | 5.35% | -40.92% |
| Return on average equity | 10.70% | -73.36% |
| Employees | 2,200 | - |
| Carbon Disclosure Rating | - | - |
Address
11730 Plaza America Drive
RESTON, VA 20190-4764
United States - Map
+1-703-7076900 (Phone)
+1-703-7076901 (Fax)
RESTON, VA 20190-4764
United States - Map
+1-703-7076900 (Phone)
+1-703-7076901 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
NCI, Inc. (NCI) is a provider of information technology (IT) and professional services and solutions to United States Federal Government Agencies. The Company�s core capabilities include enterprise systems management; network engineering; cybersecurity and information assurance; software development and systems engineering; program management and lifecycle support; engineering and logistics; health IT and informatics, and training and simulation. It provides these services to Defense, Intelligence, and Civilian Agencies. It conducts the majority of business within the United States. Substantially all of the Company�s revenue was derived from contracts with the United States Federal Government, directly as a prime contractor or as a subcontractor. On April 1, 2011, NCI completed the purchase of 100% interests in AdvanceMed Corporation (AdvanceMed).
Officers and directors
| Charles K. Narang | Chairman of the Board, Chief Executive Officer | |
| Brian J. Clark | President, Director | |
| Lucas J. Narel | Chief Financial Officer, Executive Vice President, Treasurer | |
| Marco F. de Vito | Chief Operating Officer | |
| Michele R. Cappello | Senior Vice President, General Counsel | |
| James P. Allen | Independent Director | |
| John E. Lawler | Independent Director | |
| Paul V. Lombardi | Independent Director | |
| J. Patrick McMahon | Independent Director | |
| Philip O. Nolan | Independent Director |